Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes.
about
Attrition among human immunodeficiency virus (HIV)- infected patients initiating antiretroviral therapy in China, 2003-2010Treatment for anemia in people with AIDSThe rise of multiple imputation: a review of the reporting and implementation of the method in medical researchOutcomes of antiretroviral therapy in Vietnam: results from a national evaluationA screen-and-treat strategy targeting visceral leishmaniasis in HIV-infected individuals in endemic East African countries: the way forward?CD4 count slope and mortality in HIV-infected patients on antiretroviral therapy: multicohort analysis from South AfricaMortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1-infected adults receiving antiretroviral therapy in Africa and Asia: data from the ANRS 12222 collaborationIncreasing trends in HIV prevalence among people aged 50 years and older: evidence from estimates and survey data.Mortality trends in the era of antiretroviral therapy: evidence from the Network for Analysing Longitudinal Population based HIV/AIDS data on Africa (ALPHA).Simultaneous Treatment of Missing Data and Measurement Error in HIV Research Using Multiple Overimputation.Hematological manifestations of human immunodeficiency virus infection and the effect of highly active anti-retroviral therapy on cytopenia.Changing predictors of mortality over time from cART start: implications for care.Sex differences in HIV outcomes in the highly active antiretroviral therapy era: a systematic reviewEffects of nutritional supplementation for HIV patients starting antiretroviral treatment: randomised controlled trial in Ethiopia.Temporal trends in treatment outcomes for HIV-1 and HIV-2-infected adults enrolled in Côte d'Ivoire's national antiretroviral therapy program.Cohort profile: Antiretroviral Therapy Cohort Collaboration (ART-CC).Development and external validation of a clinical prognostic score for death in visceral leishmaniasis patients in a high HIV co-infection burden area in Ethiopia.Correcting mortality for loss to follow-up: a nomogram applied to antiretroviral treatment programmes in sub-Saharan Africa.Four-year treatment outcomes of adult patients enrolled in Mozambique's rapidly expanding antiretroviral therapy program.Improved antiretroviral treatment outcome in a rural African setting is associated with cART initiation at higher CD4 cell counts and better general health condition.Antiretroviral treatment reverses HIV-associated anemia in rural TanzaniaTotal lymphocyte count is a good marker for HIV-related mortality and can be used as a tool for starting HIV treatment in a resource-limited setting.Anti-retroviral treatment outcomes among older adults in Zomba district, Malawi.Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study.Combining qualitative and quantitative evidence to determine factors leading to late presentation for antiretroviral therapy in Malawi.Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studiesEngaging men in prevention and care for HIV/AIDS in AfricaLow risk of attrition among adults on antiretroviral therapy in the Rwandan national program: a retrospective cohort analysis of 6, 12, and 18 month outcomesGender differences in immune reconstitution: a multicentric cohort analysis in sub-Saharan Africa.Total lymphocyte count is a reliable surrogate marker for CD4 cell counts after the first year of antiretroviral therapy: data from an Indonesian cohort study.Profile of blood cell abnormalities among antiretroviral therapy naïve HIV patients attending the Yaounde University Teaching Hospital, CameroonHigh prevalence of tuberculosis and serious bloodstream infections in ambulatory individuals presenting for antiretroviral therapy in Malawi.Retention in a NGO supported antiretroviral program in the Democratic Republic of Congo.Cost-effectiveness of early initiation of first-line combination antiretroviral therapy in Uganda.Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: a multicentre cohort study.Uptake of home-based voluntary HIV testing in sub-Saharan Africa: a systematic review and meta-analysis.Household-based HIV counseling and testing as a platform for referral to HIV care and medical male circumcision in Uganda: a pilot evaluationWhy the proportion of transmission during early-stage HIV infection does not predict the long-term impact of treatment on HIV incidenceEstimation of HIV-testing rates to maximize early diagnosis-derived benefits at the individual and population levelRisk factors for late-stage HIV disease presentation at initial HIV diagnosis in Durban, South Africa.
P2860
Q21134515-4228F19F-41AA-41B4-BBE9-5EC606F764C5Q24235994-B6F6BDAE-E526-484D-8920-AB1C032E1BAEQ26828889-0FC45629-DDE0-4C47-968A-BD534CAD8A30Q28486180-1F80589D-4B13-40EF-9DE6-26F65E6E693FQ28541690-348FA08A-2578-4E1C-8788-B65B96DB43FDQ28703565-9CAD0063-4554-4F1B-AE6E-E5B1D652B5F8Q30583563-A5DA3950-8B2C-447F-BEFD-89C968B77CFAQ30851182-2D05138E-8B62-4E02-BA93-16ED08F1E1CDQ30870461-9DA1C407-BFF0-480E-8C9D-E2B033787275Q30982961-9BC94930-C094-4D31-B41F-22D1FC293177Q33399256-36D76C7C-F633-4755-997A-B22F9FD7069AQ33564975-E6D19688-907B-43EF-9C38-C058033318D1Q33566578-BB5AD028-36A7-4333-BB5C-E97EBC19A67DQ33618988-CF55F928-9D18-48E3-9EFF-9AEECEB21FD6Q33670735-166BC15B-CE43-4AEC-91DF-C67D1C29ED4BQ33736040-7F8BAA95-BA95-4252-9FAD-EFA8D13AA280Q33764787-6E7D7116-389C-44BA-AE3A-0E96C5998519Q33803701-402B9866-A788-4CDE-8F3A-23FEABA9837BQ33869315-C40CBFF9-AACD-40BE-AA97-AE1CB993D71AQ33876965-A2356B8C-6F55-4CA1-856A-9A809A2A1988Q33957276-516ADA23-B92D-49C5-930C-4823E4C0597AQ34007595-2A3AD9C9-049F-48B4-BDB7-CF087ACFB569Q34059653-18790F11-E7E2-4AB1-8738-B57825B86243Q34081339-1622FD7F-09D7-40D5-9FFE-5F0671FC47B4Q34082969-7FFB1723-649F-4524-93AF-05C36E8AFC24Q34155253-163E5747-E857-48BB-B3B4-5AA1FAEFE8EBQ34162204-546EA7D9-93F1-4E1A-B45D-C64D0706DCB9Q34169040-844D005D-3BD6-4F8C-8991-45377CDF61A4Q34170487-C986C350-1058-4FF0-8075-732C808FD7C7Q34172027-0EE804F5-B541-46F0-BA7A-838FA450B5EFQ34184672-ED229B06-7D29-4B22-87F4-57B70065C5FDQ34326041-D4D4D6F1-0AF1-46DD-AEDC-A5A52525DAF6Q34345476-37733557-6434-4963-B73E-4FEA36231C06Q34401635-CD7AB234-F8C7-4F88-8E3B-D635BEDFA093Q34413586-577FC7DF-0AB0-427D-8088-44EB1367FB9FQ34504884-4BA31FB4-FBB1-42B1-BFF0-5DD5061AF12EQ34525382-BF1A9BA6-F270-43A9-902C-50289F4166A6Q34526461-C698EF75-240D-43D4-9FFA-D1ACB89C3F73Q34544751-FD11D9B2-61FB-4727-AC15-BE50ED4EA63DQ34576363-0F5AB0CC-E06F-4431-8133-48364A4DEF93
P2860
Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Prognosis of patients with HIV ...... alysis of scale-up programmes.
@ast
Prognosis of patients with HIV ...... alysis of scale-up programmes.
@en
type
label
Prognosis of patients with HIV ...... alysis of scale-up programmes.
@ast
Prognosis of patients with HIV ...... alysis of scale-up programmes.
@en
prefLabel
Prognosis of patients with HIV ...... alysis of scale-up programmes.
@ast
Prognosis of patients with HIV ...... alysis of scale-up programmes.
@en
P2093
P2860
P50
P921
P1433
P1476
Prognosis of patients with HIV ...... alysis of scale-up programmes.
@en
P2093
Eugene Messou
IeDEA Southern Africa and West Africa
Jonathan A C Sterne
P2860
P304
P356
10.1016/S0140-6736(10)60666-6
P407
P577
2010-07-15T00:00:00Z